Janssen Robert

Avg. Two Year Performance

(38%) Avg. Purchase Return
(17%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%10%(16%)(23%)(38%)
Purchase Success Rate2 of 42 of 41 of 41 of 40 of 4
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 50 of 50 of 50 of 50 of 5

Dynavax Technologies Corp.

Drugs » Drug Manufacturers - Other

SVP and CMO:

Holdings: 58.68K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--